Optimizing the Process Parameters for Encapsulation of Linamarin into PLGA Nanoparticles Using Double Emulsion Solvent Evaporation Technique

被引:19
作者
Hussein, Ahmed S. [1 ,2 ]
Abdullah, Norhafizah [2 ]
Fakru'l-Razi, A. [2 ]
机构
[1] Univ Putra Malaysia, Inst Adv Technol, Adv Mat & Nanotechnol Lab, Upm Serdang 43400, Selangor, Malaysia
[2] Univ Putra Malaysia, Fac Engn, Dept Chem & Environm Engn, Upm Serdang 43400, Selangor, Malaysia
关键词
Biodegradable; Drug delivery systems; Linamarin; Nanoparticles; Polyesters; IN-VITRO RELEASE; BIODEGRADABLE POLYMERIC MICROSPHERES; PARTICLE-SIZE; CONTROLLED DELIVERY; FACTORIAL DESIGN; ORAL DELIVERY; POLY(D; L-LACTIDE-CO-GLYCOLIDE); NANOPARTICLES; PHYSICOCHEMICAL CHARACTERIZATION; FORMULATION VARIABLES; COPOLYMER COMPOSITION;
D O I
10.1002/adv.21295
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
Linamarin-loaded poly(lactide-co-glycolide) (PLGA) nanoparticles were prepared by using a double emulsion solvent evaporation method using polyvinyl alcohol as a surfactant. A two-factor full factorial design, BoxBehnken design and surface response methodology, were employed to improve the nanoparticle yield, particle size, and drug encapsulation efficiency by determining the optimum levels of the process parameters, namely the polymer concentration, surfactant concentration, and homogenization speed. Both linear and quadratic empirical models were developed to express each response parameter as a function of the studied factors. A total of 12 and 17 experimental runs were necessary to obtain adequate empirical models (p < 0.05) for both factorial and BoxBehnken designs, respectively. The final optimum values for the polymer concentration, surfactant concentration, and homogenization speed were determined at 9.8 mg/mL, 50 mg/mL, and 23,000 rpm, respectively. Formulations obtained at this optimum preparing condition resulted on average 96% yield, 61.2% drug encapsulation efficiency, and 144.6 nm particle size. However, all prepared nanoparticles showed some kind of controlled drug release; most likely the final optimized nanoparticles exhibited the most biphasic controlled drug release profile with a minimal burst release and overall drug release of <30% in 120 h of incubation. (c) 2012 Wiley Periodicals, Inc. Adv Polym Techn 32: E486E504, 2013; View this article online at wileyonlinelibrary.com. DOI 10.1002/adv.21295
引用
收藏
页码:E486 / E504
页数:19
相关论文
共 82 条
  • [51] Montgomery D.C., 2001, Design and Analysis of Experiments
  • [52] A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®):: PLGA nanoparticles containing vitamin E TPGS
    Mu, L
    Feng, SS
    [J]. JOURNAL OF CONTROLLED RELEASE, 2003, 86 (01) : 33 - 48
  • [53] Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method
    Murakami, H
    Kobayashi, M
    Takeuchi, H
    Kawashima, Y
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 187 (02) : 143 - 152
  • [54] Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method
    Nii, T
    Ishii, F
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 298 (01) : 198 - 205
  • [55] Poly(lactic-co-glycolic acid) nanospheres and microspheres for short- and long-term delivery of bioactive ciliary neurotrophic factor
    Nkansah, Michael K.
    Tzeng, Stephany Y.
    Holdt, Adam M.
    Lavik, Erin B.
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2008, 100 (05) : 1010 - 1019
  • [56] Preparation of microspheres by the solvent evaporation technique
    ODonnell, PB
    McGinity, JW
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1997, 28 (01) : 25 - 42
  • [57] Freeze-dried nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution
    Ohshima, Hiroyuki
    Miyagishima, Atsuo
    Kurita, Takurou
    Makino, Yuji
    Iwao, Yasunori
    Sonobe, Takashi
    Itai, Shigeru
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 377 (1-2) : 180 - 184
  • [58] Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles
    Panyam, J
    Dali, MA
    Sahoo, SK
    Ma, WX
    Chakravarthi, SS
    Amidon, GL
    Levy, RJ
    Labhasetwar, V
    [J]. JOURNAL OF CONTROLLED RELEASE, 2003, 92 (1-2) : 173 - 187
  • [59] Parikh RH, 2003, AAPS PHARMSCITECH, V4, P1
  • [60] Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain
    Pillay, Samantha
    Pillay, Viness
    Choonara, Yahya E.
    Naidoo, Dinesh
    Khan, Riaz A.
    du Toit, Lisa C.
    Ndesendo, Valence M. K.
    Modi, Girish
    Danckwerts, Michael P.
    Iyukee, Sunny E.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 382 (1-2) : 277 - 290